Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001358403-17-000139
Filing Date
2017-07-17
Accepted
2017-07-17 16:20:03
Documents
1
Period of Report
2017-07-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_150032279013589.html 4  
1 FORM 4 wf-form4_150032279013589.xml 4 8307
  Complete submission text file 0001358403-17-000139.txt   9816
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

EIN.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030
Business Address
Moseley Ken (Reporting) CIK: 0001626895 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 17967740